Synapse - Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma

Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma Research Letter

Authors:	Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Hamlin, P. A.; Mead, E.; Noy, A.; Lia Palomba, M.; Santomasso, B. D.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Korc-Grodzicki, B.; Kim, S. J.; Silverberg, M. L.; Brooklyn, C. A.; Devlin, S. M.; Perales, M. A.
Title:	Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
Journal Title:	Haematologica
Volume:	106
Issue:	1
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2021-01-01
Start Page:	255
End Page:	258
Language:	English
ACCESSION:	WOS:000606523300009
DOI:	10.3324/haematol.2019.243246
PROVIDER:	wos
PMCID:	PMC7776258
PUBMED:	32079691
Notes:	Letter -- Source: Wos